Literature DB >> 29313968

Cochrane systematic review and meta-analysis of the impact of psychological treatments for people with epilepsy on health-related quality of life.

Rosa Michaelis1,2, Venus Tang3,4, Janelle L Wagner5, Avani C Modi6, W Curt LaFrance7, Laura H Goldstein8, Tobias Lundgren9, Markus Reuber10.   

Abstract

OBJECTIVE: Given the significant impact epilepsy can have on health-related quality of life (HRQoL) of individuals with this condition and their families, there is great clinical interest in evidence-based psychological treatments aimed at enhancing well-being in people with epilepsy (PWE). An evaluation of the current evidence is needed to assess the effects of psychological treatments for PWE on HRQoL outcomes to inform future therapeutic recommendations and research designs.
METHODS: The operational definition of psychological treatments included a broad range of interventions that use psychological or behavioral techniques designed to improve HRQoL, psychiatric comorbidities, and seizure frequency and severity for adults and children with epilepsy. A systematic literature search was conducted in line with Cochrane criteria for randomized controlled trials (RCTs) and quasi-RCTs investigating psychological treatments and using HRQoL outcome measures as primary or secondary outcome measures. Standard methodological procedures required by the Cochrane Collaboration were used for data collection and analysis.
RESULTS: Twenty-four completed RCTs were included in this review (2439 participants). Based on satisfactory methodological homogeneity, data from 9 studies (468 participants) providing Quality of Life in Epilepsy-31 (QOLIE-31) outcomes were pooled for meta-analyses, showing significant mean changes for QOLIE-31 total score and 6 subscales. The significant mean changes of QOLIE-31 total score (mean improvement of 5.68 points; 95% confidence interval = 3.11-8.24, P < .0001) and 3 subscales (emotional well-being, energy/fatigue, overall quality of life [QoL]) exceeded the threshold of minimally important change, indicating a clinically meaningful postintervention improvement of QoL. Overall, the meta-analysis quality of evidence was characterized as "moderate" due to the risk of bias present in 8 of the 9 included studies (Handbook for Systematic Reviews of Interventions, Version 5.1.0, 2011, Chapters 8 and 12). A narrative synthesis was conducted for all trials and outcomes that were not entered in the meta-analysis. SIGNIFICANCE: These results provide moderate-quality evidence that psychological treatments for adults with epilepsy may enhance HRQoL in people with epilepsy. Wiley Periodicals, Inc.
© 2018 International League Against Epilepsy.

Entities:  

Keywords:  anxiety; depression; nonadherence; psychoeducation; self-management

Mesh:

Year:  2018        PMID: 29313968     DOI: 10.1111/epi.13989

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

1.  A 6-month prospective randomized controlled trial of remotely delivered group format epilepsy self-management versus waitlist control for high-risk people with epilepsy.

Authors:  Martha Sajatovic; Kari Colon-Zimmermann; Mustafa Kahriman; Edna Fuentes-Casiano; Hongyan Liu; Curtis Tatsuoka; Kristin A Cassidy; Samden Lhatoo; Douglas Einstadter; Peijun Chen
Journal:  Epilepsia       Date:  2018-08-10       Impact factor: 5.864

2.  Epilepsy and quality of life: what does really matter?

Authors:  Mario Tombini; Giovanni Assenza; Livia Quintiliani; Lorenzo Ricci; Jacopo Lanzone; Vincenzo Di Lazzaro
Journal:  Neurol Sci       Date:  2021-01-15       Impact factor: 3.307

Review 3.  Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis.

Authors:  Miaomiao Chen; Xuehan Zhang; Yi Xiong; Gaosi Xu
Journal:  Int Urol Nephrol       Date:  2022-09-25       Impact factor: 2.266

4.  Effectiveness of a Self-Management Program to Improve Cognition and Quality of Life in Epilepsy: A Pragmatic, Randomized, Multicenter Trial.

Authors:  Nicholas A Streltzov; Samantha S Schmidt; Lindsay M Schommer; Wenyan Zhao; Tor D Tosteson; Morgan T Mazanec; Elaine T Kiriakopoulos; Felicia Chu; Heidi L Henninger; Keith Nagle; Robert M Roth; Barbara Jobst
Journal:  Neurology       Date:  2022-04-06       Impact factor: 11.800

Review 5.  Impaired vigilance networks in temporal lobe epilepsy: Mechanisms and clinical implications.

Authors:  Dario J Englot; Victoria L Morgan; Catie Chang
Journal:  Epilepsia       Date:  2020-01-04       Impact factor: 5.864

6.  Long-Term, Targeted Delivery of GDNF from Encapsulated Cells Is Neuroprotective and Reduces Seizures in the Pilocarpine Model of Epilepsy.

Authors:  Giovanna Paolone; Chiara Falcicchia; Francesca Lovisari; Merab Kokaia; William J Bell; Tracie Fradet; Mario Barbieri; Lars U Wahlberg; Dwaine F Emerich; Michele Simonato
Journal:  J Neurosci       Date:  2019-01-21       Impact factor: 6.167

7.  Depression in patients with epilepsy: screening, diagnosis and management.

Authors:  Amina Chentouf
Journal:  Tunis Med       Date:  2021 Mai

8.  The efficacy of fish oil in preventing coronary heart disease: A systematic review and meta-analysis.

Authors:  Gaohong Wu; Qingyang Ji; Huiwen Huang; Xueping Zhu
Journal:  Medicine (Baltimore)       Date:  2021-09-17       Impact factor: 1.889

9.  Staples versus sutures for skin closure in hip arthroplasty: a meta-analysis and systematic review.

Authors:  Zirui Liu; Binfeng Liu; Hao Yang; Liang Zhao
Journal:  J Orthop Surg Res       Date:  2021-12-24       Impact factor: 2.359

10.  Comparative efficacy and safety of different drugs for bipolar disorder complicated with anxiety disorder: A protocol for systematic review and network meta-analysis.

Authors:  Li Yang; Meili Yan; Li Du; Shasha Hu; Zhigang Zhang
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.